Aberdeen Group
GMED icon

Aberdeen Group’s Globus Medical GMED Stock Holding History

Aberdeen Group’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-17,690
Closed -$878K – 970
2023
Q3 		$878K Hold
17,690
– – ﹤0.01% 771
2023
Q2 		$1.05M Hold
17,690
– – ﹤0.01% 788
2023
Q1 		$1M Hold
17,690
– – ﹤0.01% 794
2022
Q4 		$1.31M Sell
17,690
-37,800
-68% -$2.57M ﹤0.01% 747
2022
Q3 		$3.31M Buy
55,490
+164
+0.3% +$9.88K 0.01% 619
2022
Q2 		$3.18M Sell
55,326
-4,911
-8% -$323K 0.01% 644
2022
Q1 		$4.52M Sell
60,237
-162,979
-73% -$11.3M 0.01% 600
2021
Q4 		$16.1M Buy
223,216
+509
+0.2% +$36.9K 0.04% 386
2021
Q3 		$17.4M Buy
222,707
+20,163
+10% +$1.62M 0.04% 380
2021
Q2 		$15.7M Sell
202,544
-78,036
-28% -$5.55M 0.03% 398
2021
Q1 		$17.3M Sell
280,580
-440,082
-61% -$27.9M 0.04% 370
2020
Q4 		$47M Sell
720,662
-580,519
-45% -$33.4M 0.11% 158
2020
Q3 		$64.4M Buy
1,301,181
+128,580
+11% +$6.63M 0.17% 123
2020
Q2 		$56M Buy
1,172,601
+38,819
+3% +$1.87M 0.15% 129
2020
Q1 		$48.2M Sell
1,133,782
-172,356
-13% -$8.52M 0.15% 125
2019
Q4 		$76.9M Sell
1,306,138
-3,499
-0.3% -$190K 0.19% 103
2019
Q3 		$66.9M Sell
1,309,637
-113,022
-8% -$5.38M 0.17% 112
2019
Q2 		$60.2M Buy
1,422,659
+228,199
+19% +$9.91M 0.13% 142
2019
Q1 		$59M Buy
1,194,460
+133,551
+13% +$6.04M 0.13% 135
2018
Q4 		$45.5M Sell
1,060,909
-173,648
-14% -$8.66M 0.11% 165
2018
Q3 		$70.1M Buy
1,234,557
+39,338
+3% +$2.07M 0.13% 150
2018
Q2 		$60.3M Sell
1,195,219
-36,331
-3% -$1.89M 0.12% 165
2018
Q1 		$61.4M Sell
1,231,550
-491,315
-29% -$23.1M 0.12% 166
2017
Q4 		$70.8M Sell
1,722,865
-401,650
-19% -$14.1M 0.14% 145
2017
Q3 		$63.2M Buy
+2,124,515
New +$64.9M 0.12% 172

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Aberdeen Group's GMED Position: Q4 2023 in Review

Aberdeen Group sold out of Globus Medical (GMED) in Q4 2023, closing a stake of 17,690 shares — an estimated $878K sold.

Aberdeen Group first reported a position in GMED in Q3 2017 and held it in 25 quarters. The position peaked at $76.9M in Q4 2019. 408 funds tracked by Wall St. Rank hold GMED as of Q4 2023.

  • Aberdeen Group reported no remaining Globus Medical position as of Q4 2023 after selling out during the quarter.
  • Aberdeen Group sold 17,690 Globus Medical shares in Q4 2023, an estimated $878K.
  • Aberdeen Group first reported a position in Globus Medical in Q3 2017 and held it in 25 quarters.
  • Aberdeen Group's Globus Medical position peaked at $76.9M in Q4 2019.
  • 408 funds tracked by Wall St. Rank held Globus Medical as of Q4 2023.

Based on Aberdeen Group's 13F filing for Q4 2023, filed 31 Jan 2024.